Standigm named as a Tech Innovator in Generative AI in Drug Discovery use case

SEOUL, South Korea, Dec. 19, 2023 /PRNewswire/ — Standigm, a company using artificial intelligence (AI) technology for drug discovery and development, today announced that it has been included in a recent Gartner report, entitled, Emerging Tech: Tech Innovators for Generative AI…

Click here to view original post

Advertisement — Advertise with Biotech Networks